The best of R&I and around the web, handpicked by our editors.
White papers, service directory and conferences for the R&I community.
Web replica of the print magazine.
In part four of our series we look at high impact drug classes like topicals, compound kits and combo packs, and specialty medications. While these classes represent proportionately low volume, they can be associated with exponentially significant costs.
In part three of our series we’ll look at opioids, which continue to decrease in proportion to overall scripts and costs, with favorable trends in Morphine Equivalent Dose (MED), duration of use, and access to guideline-supported measures.
In part two of Coventry’s annual drug trends series we’ll provide analysis on the trends experienced within our combined in- and out-of-network channels.
In part one of this year’s series we reflect on the retail and mail-order trends our clients experienced between 2017 and 2018.
On average, people receive $2 in increased sale price for every $1 they put into staging a home. With a 100% return on investment, spending a little cash staging your next home is a no-brainer!
Opioids cause a variety of side effects that can spread across the body, which can in turn require more medication to treat these side effects. This can cause added concerns for patient safety due to excessive polypharmacy (concurrent use of multiple medications).
Events of 2013 point the way forward next year. Buzz words: cyber, health care and property.
Newsletters
Risk Central
Digital Edition
